4 results for author:"Fredenburg R.A." in Literature citations
Results Customize
› Repeat search in UniProtKB (17)
| Membrane-associated farnesylated UCH-L1 promotes alpha-synuclein neurotoxicity and is a therapeutic target for Parkinson's disease. Liu Z., Meray R.K., Grammatopoulos T.N., Fredenburg R.A., Cookson M.R., Liu Y., Logan T., Lansbury P.T. Jr. Proc. Natl. Acad. Sci. U.S.A. 106:4635-4640(2009) · UniProtKB (1) · Mapped (10) |
| Phosphorylation at Ser-129 but not the phosphomimics S129E/D inhibits the fibrillation of alpha-synuclein. Paleologou K.E., Schmid A.W., Rospigliosi C.C., Kim H.Y., Lamberto G.R., Fredenburg R.A., Lansbury P.T. Jr., Fernandez C.O., Eliezer D., Zweckstetter M. et al. J. Biol. Chem. 283:16895-16905(2008) · Mapped (7) |
| The impact of the E46K mutation on the properties of alpha-synuclein in its monomeric and oligomeric states. Fredenburg R.A., Rospigliosi C., Meray R.K., Kessler J.C., Lashuel H.A., Eliezer D., Lansbury P.T. Jr. Biochemistry 46:7107-7118(2007) · Mapped (7) |
| Molecular cloning and sequence analysis of the complestatin biosynthetic gene cluster. Chiu H.T., Hubbard B.K., Shah A.N., Eide J., Fredenburg R.A., Walsh C.T., Khosla C. Proc. Natl. Acad. Sci. U.S.A. 98:8548-8553(2001) · UniProtKB (16) |